Related Experiment Videos
Inflammatory markers in childhood asthma
S Kristjánsson1, I L Strannegård, G Wennergren
1Department of Paediatrics, Göteborg University, Sweden.
Annals of Medicine
|October 1, 1996
Summary
Asthma is a chronic inflammatory disease. Measuring eosinophil proteins like ECP and urinary EPX can help monitor airway inflammation, especially in children.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Biochemistry
Background:
- Asthma pathogenesis is linked to chronic airway inflammation, even in mild cases.
- Inflammatory mediators drive bronchoconstriction and hyper-reactivity in asthma.
- Current anti-inflammatory treatments necessitate reliable markers for airway inflammation.
Purpose of the Study:
- To identify and evaluate biomarkers for monitoring airway inflammation in asthma.
- To address the challenges of assessing inflammation in pediatric asthma patients.
- To explore the role of eosinophil granulocytes and their products as inflammatory markers.
Main Methods:
- Review of existing studies on asthma pathogenesis and inflammatory markers.
- Focus on eosinophil granulocytes and their secreted proteins (e.g., ECP, EPX).
- Consideration of non-invasive methods for pediatric asthma management.
Main Results:
- Eosinophil granulocytes play a key role in asthmatic airway inflammation.
- Eosinophil cationic protein (ECP) shows potential as a complementary marker to lung function tests.
- Urinary eosinophil protein X (EPX) is a promising non-invasive biomarker for pediatric asthma.
Conclusions:
- Airway inflammation is central to asthma, necessitating effective monitoring tools.
- ECP measurement can aid in assessing inflammation alongside lung function.
- Urinary EPX offers a valuable, non-invasive option for monitoring pediatric asthma inflammation.